Dinsmore Christopher

Chief Scientific Officer at Kronos Bio, Inc.

Sold, on record
$783k
Dollars the filings state
Form 4 sales
9
Latest Jan 4, 2024
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Kronos Bio, Inc.Plan not stated
    Sep 7, 2021 2021

    Sold 9,189 shares at $21.91 ($201k)

    Dinsmore Christopher, Chief Scientific Officer

    Sold 8.7% of holdings ($2.3M position)96,360 shares leftFiling

  2. 2 Form 4 sale Kronos Bio, Inc.Plan not stated
    Oct 4, 2021 +27 days

    Sold 9,189 shares at $20.81 ($191k)

    Dinsmore Christopher, Chief Scientific Officer

    Sold 8.7% of holdings ($2.2M position)96,360 shares leftFiling

  3. 3 Form 4 sale Kronos Bio, Inc.Plan not stated
    Dec 13, 2021 +70 days

    Sold 11,386 shares at $12.37 ($141k)

    Dinsmore Christopher, Chief Scientific Officer

    Sold 11.8% of holdings ($1.2M position)84,974 shares left1.2x usual sizeFiling

  4. 4 Form 4 sale Kronos Bio, Inc.Plan not stated
    Dec 12, 2022 +364 days

    Sold 9,138 shares at $1.81 ($17k)

    Dinsmore Christopher, Chief Scientific Officer

    Sold 5.3% of holdings ($311k position)162,936 shares left1x usual sizeFiling

  5. 5 Form 4 sale Kronos Bio, Inc.Plan not stated
    Feb 24, 2023 +74 days

    Sold 6,291 shares at $1.74 ($11k)

    Dinsmore Christopher, Chief Scientific Officer

    Sold 2.2% of holdings ($507k position)285,001 shares left0.7x usual sizeFiling

  6. 6 Form 4 sale Kronos Bio, Inc.No plan
    Jul 6, 2023 +132 days

    Sold 6,634 shares at $1.75 ($12k)

    Dinsmore Christopher, Chief Scientific Officer

    No 10b5-1 planSold 2.3% of holdings ($499k position)278,367 shares left0.7x usual sizeFiling

  7. 7 Form 4 sale Kronos Bio, Inc.No plan
    Dec 12, 2023 +159 days

    Sold 10,032 shares at $1.31 ($13k)

    Dinsmore Christopher, Chief Scientific Officer

    No 10b5-1 planSold 3.6% of holdings ($365k position)268,335 shares left1.3x usual sizeFiling

  8. 8 Form 4 sale Kronos Bio, Inc.No plan
    Jan 4, 2024 +23 days

    Sold 7,366 shares at $1.18 ($9k)

    Dinsmore Christopher, Chief Scientific Officer

    No 10b5-1 planSold 2.7% of holdings ($317k position)260,969 shares left0.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Dinsmore Christopher
Source
Jan 4, 2024Jan 5, 2024Kronos Bio, Inc.Chief Scientific OfficerForm 4 sale7,366$9k2.7%No planSEC
Dec 12, 2023Dec 13, 2023Kronos Bio, Inc.Chief Scientific OfficerForm 4 sale10,032$13k3.6%No planSEC
Jul 6, 2023Jul 7, 2023Kronos Bio, Inc.Chief Scientific OfficerForm 4 sale6,634$12k2.3%No planSEC
Feb 24, 2023Feb 24, 2023Kronos Bio, Inc.Chief Scientific OfficerForm 4 sale6,291$11k2.2%Plan not statedSEC
Dec 12, 2022Dec 14, 2022Kronos Bio, Inc.Chief Scientific OfficerForm 4 sale9,138$17k5.3%Plan not statedSEC
Dec 13, 2021Dec 15, 2021Kronos Bio, Inc.Chief Scientific OfficerForm 4 sale11,386$141k11.8%Plan not statedSEC
Oct 4, 2021Oct 4, 2021Kronos Bio, Inc.Chief Scientific OfficerForm 4 sale9,189$191k8.7%Plan not statedSEC
Sep 7, 2021Sep 9, 2021Kronos Bio, Inc.Chief Scientific OfficerForm 4 sale9,189$201k8.7%Plan not statedSEC
Aug 2, 2021Aug 3, 2021Kronos Bio, Inc.Chief Scientific OfficerForm 4 sale9,189$189k8.7%Plan not statedSEC